4//SEC Filing
Holm-Jorgensen Rasmus 4
Accession 0000905148-24-003293
CIK 0001781174other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 6:10 PM ET
Size
5.2 KB
Accession
0000905148-24-003293
Insider Transaction Report
Form 4
Holm-Jorgensen Rasmus
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+90,090→ 90,090 totalExercise: $5.70Exp: 2034-02-28→ Common Stock (90,090 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2025, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950496
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 6:10 PM ET
- Size
- 5.2 KB